Objective-To investigate the formation of nitric oxide (NO) by peritoneal macrophages in three inbred strains of rats differing both in their susceptibility to the induction ofadjuvant arthritis (AA) and in the severity of the disease. Methods 
Although exact understanding of the aetiology and pathogenetic aspects of adjuvant induced arthritis (AA) in the rat remains to be established, it is generally regarded as a T cell dependent chronic inflammatory disease of autoimmune origin.' 2 Activated T lymphocytes are a well recognised major source of a number of cytokines,3 some of which, either per se or in co-operation with other macrophage derived factors (monokines), stimulate biosynthesis of nitric oxide (NO). 4 Cytokines such as interferon gamma (IFN-y), tumour necrosis factor a (TNFox), interleukin (IL)-1, IL-2, or IL-6, have been shown to be implicated in the development of immune arthritis.5`8 It is not surprising, therefore, that changes in NO production have been found to be associated with arthritic immunopathies,9 though the actual relationship of NO to disease pathogenesis is not well defined.
The aim of this study was to investigate changes in the capability of macrophages to generate NO during development of AA in rats, and to examine if these changes are related to the inducibility or severity of the disease. control animals not treated with M. tb, but production was significantly enhanced (p < 0-001) after in vitro coincubation of cells with LPS.
Materials and methods

ANIMALS
Macrophages from adjuvant treated rats produced nitrites in markedly increased amounts (p < 0001) which differed between the genotypes. However, when the cells were cultured in the presence of LPS, their augmented ability to produce NO was reduced to that of LPS untreated macrophages from control animals not injected with M. tb, except for those of strain BN, in which the return to normal values was incomplete.
The disease free F344 animals (nonresponders) showed an increased production of NO which was indistinguishable from that detected in their F344 diseased (responders) counterparts. In this group, however, the increase was not affected by the in vitro presence of LPS.
A trypan blue exclusion test showed that 87-93% of cells from both control and arthritic animals remained viable at the end of the 24 hour period of culture, regardless of the presence or absence of LPS.
DYNAMICS OF CHANGES IN PRODUCT>ION OF NO
Significantly increased production of NO was observed throughout the study period (days 5, 11, and 21) (fig 2) . NO production remained increased in the in vitro presence of LPS on day 5 (p > 0.20), but had decreased significantly on days 11 and 21 (p < 0-001).
Discussion
These results demonstrate that peritoneal macrophages from rats injected with mycobacterial adjuvant produced enhanced amounts of NO and that this effect preceded the onset of secondary arthritic lesions. These findings are compatible with those of Ialenti et al'°who showed that the severity of arthritis in Lewis rats was paralleled by pharmacologically manipulated production of NO by peritoneal macrophages. Others have reported a reduction of arthritic swelling in rats by inhibition of L-arginine dependent formation of NO." 12 Considered alone, these data might suggest that increased production of NO is one of the pathogenetic mechanisms of AA; however, our comparative genetic study does not support such an unambiguous conclusion. We found also that macrophages from M. tb treated (but disease-free) rats of the F344 strain produced similarly enhanced concentrations of NO. Furthermore, we found no association between severity of the AA and the magnitude of the increase in NO production; rather, the increase in production of NO was greater in BN rats which showed a very mild arthritic response, and least in LEW rats with the most severe AA. Moreover, changes in NO production in F344 mild responders were similar to those found in LEW rats. In addition, no quantitative differences in formation of NO existed between AA susceptible and AA resistant F344 rats. Overall, these findings show that increased production of NO by peritoneal macrophages from adjuvant treated rats is not a correlate of genetically controlled disease inducibility, nor is it a biochemical marker of disease severity. It remains to be clarified, however, whether systemic changes in NO production, assessed here in peritoneal macrophages, reflect the situation at the site of inflammation. It cannot be excluded that local formation of NO is essential for the manifestation of arthritis. In any case, our findings support the view that NO should be regarded as a modifier rather than a direct mediator of the disease. Further pharmacogenetically designed studies to monitor constitutive and inducible NO synthase activity directly in the microenvironment of target joints and adjacent tissues will be undertaken to elucidate this problem.
Our results also show that macrophages from arthritic rats lose their enhanced capacity to generate NO when they are cultured in vitro with LPS. This effect was only expressed in AA responders, and was fully manifested at the time of onset of the swelling. It is difficult to explain the mechanism and biological significance of this phenomenon at present. Further studies are required to ascertain if 'arthritic macrophages' can secrete latent forms of downregulatory factors of NO synthesis, which may be rendered biologically active when exposed to LPS. Such biological properties are known to be inherent to transforming growth factor I313 14 which, interestingly, has been shown to be implicated in arthritic disease.6
